(secondQuint)Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt.

 An observational, multi-center, prospective cohort study to assess the effectiveness and safety of generic Imatinib (Carcemia(R)) in patients with Ph+ CML who are newly diagnosed or patients who will be switched from the reference product (Glivec(R) ) to Carcemia(R) where treatment will be prescribed by the investigator in accordance with clinical practice where no visits or intervention(s) additional to the daily practice will be performed.

 Eligible Ph+ CML patients in both cohorts will be followed up for a total of 18 months.

.

 Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt@highlight

The purpose of this observational study is to evaluate the effectiveness and safety of generic imatinib under usual clinical practice in patients of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) patients in chronic phase (CP) in Egypt